Lipid metabolism modulation is a main focus of metabolic syndrome research, an area in which many natural and synthetic chemicals are constantly being screened for in vitro and in vivo activity. Berberine, a benzylisoquinoline plant alkaloid, has been extensively investigated for its anti-obesity effects and as a potential cholesterol and triglyceride-lowering drug. We screened 11 protoberberine and 2 benzophenanthridine alkaloids for their anti-adipogenic effects on 3T3-L1 adipocytes and found that 13-methylberberine exhibited the most potent activity. 13-Methylberberine down-regulated the expression of the main adipocyte differentiation transcription factors, peroxisome proliferator-activated receptor gamma (PPARγ) and CCAAT enhancer binding protein alpha (C/EBPα), as well as their target genes. PPARγ, C/EBPα, and sterol regulatory element binding protein 1 (SREBP-1) protein levels were reduced, and this lipid-reducing effect was attenuated by an AMP-activated protein kinase (AMPK) inhibitor, indicating that the effect of this compound requires the AMPK signaling pathway. Decreased Akt phosphorylation suggested reduced de novo lipid synthesis. C-13 methyl substitution of berberine increased its accumulation in treated cells, suggesting that 13-methylberberine has improved absorption and higher accumulation compared to berberine. Our findings suggest that 13-methylberberine has potential as an anti-obesity drug.
:
Stroke is the second leading cause of death and a major cause of disability worldwide. Both modifiable and
non-modifiable risk factors can affect the occurrence of ischemic stroke at varying degrees. Among them, atherosclerosis
has been well recognized as one of the main culprits for the rising incidence of stroke-related mortality. Hence, the current
review aimed to summarize the prominent role of lipid metabolism genes such as PCSK9, ApoB, ApoA5, ApoC3, ApoE
and ABCA1 in mediating ischemic stroke occurrence.
Benzylisoquinoline alkaloids are one of the most important groups of secondary metabolites and include the economically important analgesic morphine and the antimicrobial agent berberine. To improve the productivity of these alkaloids, we investigated the effects of putative rate-limiting step enzymes in alkaloid biosynthesis. We constructed several over-expression vectors for biosynthetic enzymes and introduced them into cultured California poppy, a model isoquinoline alkaloid-producing plant. HPLC/LC-MS analysis of transgenic cells revealed that these enzymes varied in their ability to increase alkaloid production. We describe the use of a rate-limiting step gene to improve alkaloid productivity.
Recently, more studies
have aimed at identifying selective peroxisome
proliferator-activated receptor gamma (PPARγ) modulators that
transactivate the expression of PPARγ-dependent genes as partial
agonists to improve diabetic symptoms with fewer side effects compared
to classic PPARγ agonists such as thiazolidinediones. We found
that dihydrosanguinarine (DHS) treatment induced preadipocyte differentiation
and lipid droplet accumulation in 3T3-L1 cells, but this effect is
weaker than that elicited by the full PPARγ agonist troglitazone.
Furthermore, this effect was reduced by the addition of a PPARγ
antagonist, indicating the involvement of PPARγ signaling. Our
results suggest that the stimulatory effects of DHS on adipocyte differentiation
and insulin sensitivity are mediated by suppressing adenosine monophosphate-activated
protein kinase (AMPK) alpha, upregulating the expression of PPARγ
and its target genes (particularly Glut-4 and adiponectin) and reducing PPARγ phosphorylation. DHS
significantly enhanced the glucose uptake in 3T3-L1 adipocytes without
observable cytotoxicity at the effective concentration (5 μM)
applied.
Caenorhabditis elegans is a versatile, whole-organism model for bioactivity screening. However, this worm has extensive defensive mechanisms against xenobiotics which limit its use for screening of pharmacologically active compounds. In this study, we report that knockdown of nhr-8, a gene involved in the xenobiotic response, increased the worm’s sensitivity to the lipid-reducing effects of some isoquinoline alkaloids, especially berberine. On the other hand, crude extract of rhizome and cultured cells showed enhanced biological activity compared to the pure alkaloids in wild type worm, but this enhanced activity was not detected in nhr-8 RNAi worm, suggesting that some components in cell extracts might interfere with the defense response in this worm. The possibility of using C. elegans as a model for screening bioactive chemicals is discussed.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.